Alindam Ghosh

Alindam Ghosh

Auto-generated profile, based on publicly available information

Alindam Ghosh

Department of Pharmaceutical Science, DmbH Institute of Medical Science, Hooghly, West Bengal, India

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2025 in Next Research
Verified
Journal Article
Closed access
BGBikram Ghosh
Bikram Ghosh
STShahbaz Tanweer
Shahbaz Tanweer
SDSriparni Das
Sriparni Das
CDChiranjit Dey
Chiranjit Dey
AMArijit Mondal
Arijit Mondal
AGAlindam Ghosh
Alindam Ghosh

20 October 2025 in Pharmaceutical Nanotechnology
Verified
Journal Article
Closed access
PDF file
DADr. Faruk Alam
Dr. Faruk Alam
PSPrasurjya Saikia
Prasurjya Saikia
DKDurgaprasad Kemisetti
Durgaprasad Kemisetti
SMSurabhi Mandal
Surabhi Mandal
ARAmrit Kumar Rath
Amrit Kumar Rath
SSSanket Seksaria
Sanket Seksaria
Carbon nanotubes (CNTs) have emerged as extremely promising nanocarriers for drug delivery due to their superior structural, mechanical, and electrical capabilities. This study digs into recent advances in CNT-based drug delivery systems, focusing on novel functionalization strategies, hybrid nanostructures, and customized nanocarrier designs. Functionalization using polymers, peptides, and other bioactive compounds has dramatically improved CNT solubility, biocompatibility, and precise targeting. Furthermore, hybrid nanostructures that combine CNTs with nanoparticles, liposomes, or metallic components have higher drug-loading capacities, multifunctional therapeutic effectiveness, and controlled drug-release features. CNTs may be customized in size, shape, and surface chemistry, allowing for the development of precise delivery systems that are particularly useful in cancer and complicated disease therapy. However, despite these advances, cytotoxicity, regulatory limits, and difficulty with large-scale manufacturing impede clinical translation. Sustainable methods, thorough safety assessments, and advanced technology like artificial intelligence to maximize functionality and design are all necessary to overcome these obstacles. Future research should focus on overcoming these hurdles to fully realize CNTs' potential as flexible, effective, and safe nanocarriers in drug delivery applications.

20 March 2026 in Biomedical and Pharmacology Journal
Verified
Journal Article
Open access
DADr. Faruk Alam
Dr. Faruk Alam
AGAlindam Ghosh
Alindam Ghosh
ASArpan Sen
Arpan Sen
DDDebraj Dey
Debraj Dey
SGSoumya Sunder Ghora
Soumya Sunder Ghora
PCPrithviraj Chakraborty
Prithviraj Chakraborty
Biomedical and Pharmacology Journal (BPJ) is an international, open access, peer reviewed, quarterly research journal.

1 August 2025 in The Natural Products Journal
Verified
Journal Article
Closed access
PDF file
SSSaroj Singhmura
Saroj Singhmura
AGAlindam Ghosh
Alindam Ghosh
PPPARTHASARATHI PANDA
PARTHASARATHI PANDA
SBSouvik Basak
Souvik Basak
NGNilanjan Ghosh
Nilanjan Ghosh
Aims: Cuscuta reflexa Roxb. has been traditionally utilized as an ethnomedicinal agent for managing various ailments, including diabetes, jaundice, and rheumatic issues. This investigation aimed to evaluate the oral hypoglycemic and hypolipidemic effects of the hydroalcoholic extract of the aerial parts of Cuscuta reflexa (HAECR) in rats with diabetes induced by a high-fat diet (HFD) and streptozotocin (STZ). Additionally, the study sought to identify the bioactive compounds responsible for these effects in Cuscuta reflexa. Background: To date, only a few attempts have been made to isolate the lead bioactive compound from Cuscuta reflexa, highlighting the need for further exploration of this herb through bioactivityguided fractionation. The isolation and characterization of the responsible lead molecules could pave the way for developing a new, safer therapeutic option compared to conventionally used drugs. Objectives: The study aims to evaluate the oral hypoglycemic and hypolipidemic activity of hydroalcoholic extract of the aerial parts of Cuscuta reflexa (HAECR) in a high-fat diet (HFD) and streptozotocin (STZ) induced diabetic rats, along with elucidating the responsible bioactive compounds of Cuscuta reflexa. Methods: The hydroalcoholic plant extract was standardized by marker calibration by HPLC and, subsequently, phytochemical screening by LC-MS. Column chromatography was adopted to isolate bioactive compounds from the extract, which NMR, FT-IR, and MS spectroscopy subsequently characterized. Oral antihyperglycemic activity and toxicity studies were performed, and antioxidant activities were studied. Results: No deaths or behavioural changes were observed during the toxicity study up to 2000 mg/kg oral dosing. Other toxicological parameters, such as deviations in organ weights, and haematological, and histological parameters, were also not observed. 250 mg/kg dose of HAECR exhibited significant antihyperglycemic activity (56.9% reduction in blood glucose level) in diabetic rats. In the HAECR-treated groups, significant reductions were observed compared to the control group, with cholesterol levels decreasing by 57%, triglycerides by 50%, SGPT by 50%, and SGOT by 30%. Considering the extensive analytical spectroscopy interpretation results, Quercetin and Stigmasterol are the two possible isolated compounds from our extract. Conclusion: Thus, this study suggested the antihyperlipidemic and antihyperglycemic activity of HAECR, which may be attributed to phytomolecules such as Stigmasterol and Quercetin. Therefore, our findings from the investigated part of the herb could be regarded as an adjunctive agent for treating diabetes mellitus.

1 January 2023 in Pharmaspire
Verified
Journal Article
Open access
IDItishree Jogmaya Das
Itishree Jogmaya Das
TSTapan Kumar Sahu
Tapan Kumar Sahu
DKDhiraj Kumar
Dhiraj Kumar
Himansu SamalHimansu Samal
Himansu Samal
SDSuddhasattya Dey
Suddhasattya Dey
AMAnjan Mondal
Anjan Mondal
Introduction: The determination of sodium fusidate in pharmaceutical dose form was accomplished using a straightforward reverse-phase (RP) high-pressure liquid chromatography (HPLC) approach. The separation through chromatography was accomplished by isocratic elution, on Waters e2695 HPLC system with Empower-3 software and 2998 module Photo Diode Array detectors configured with a pump that delivers quaternary solvents, an automated sample injector, and a column thermostat. A validated RP-HPLC method that is reproducible, rapid, simple, precise, rugged, economical, and accurate has been developed. Materials and Methods: Separation succeeded using a Thermo Scientific Hypersil ODS (C18) Column (150 × 4.6 mm i.d. and 5 µm particle size), and methanol: 1% V/V glacial acetic acid: acetonitrile used as mobile phase in ratio of 10:30:60% v/v/v, respectively. Ultraviolet detector was used to detect the separation at a wavelength of 235 nm with 1.1 mL/min of flow rate and volume of injection of 20 μL was maintained during the elution with 10-min run time. Results: It was estimated that the retention time was 5.597 min with a correlation coefficient of 0.999, the anticipated separation was found to be linear in the concentration range of 25–150 mcg/mL and it was found out that according to ICH regulations, every validation parameter fulfilled the acceptance criteria. Conclusion: Validation of the chromatographic method was done for linearity, specificity, accuracy, precision, robustness, system suitability, limit of detection, and limit of quantification study that it can be utilized for sodium fusidate routine analysis in accordance with ICH recommendations.

27 October 2025 in Asian Journal of Chemistry
Verified
Journal Article
Open access
PDF file
DADr. Faruk Alam
Dr. Faruk Alam
MNMrinmoy Nag
Mrinmoy Nag
MJMoidul Islam Judder
Moidul Islam Judder
SMSurabhi Mandal
Surabhi Mandal
BSBhupendra Shrestha
Bhupendra Shrestha
MIMohidul Islam
Mohidul Islam
The field of nanotechnology continues to offer profound implications across biomedical, environmental and materials science domains with metallic nanoparticles (MNPs) at the forefront due to their size-dependent physical and chemical attributes. This review provides a critical evaluation of the biosynthesis of MNPs particularly gold (AuNPs) and silver nanoparticles (AgNPs) employing plant-derived phytochemicals and microbial metabolites as reducing and stabilizing agents. The biosynthetic route is compared against conventional top-down and bottom-up methods, with specific attention to the influence of synthesis parameters (e.g. pH, temperature, extract concentration) on nanoparticle morphology, yield and surface chemistry. The unique optical and surface plasmon resonance properties of noble metals are discussed in the context of their biomedical applications, notably in antimicrobial coatings, cancer therapeutics, drug delivery vectors and diagnostic platforms. Moreover, functional nanoparticles of other metals (Pd, Cu, Fe, Fe3O4, α-Fe2O4, and nZVI) are examined for their roles in catalysis, pollutant degradation and water treatment. The review also delineates analytical techniques employed in nanoparticle characterization, encompassing structural, compositional, and surface profiling. Finally, the clinical relevance and translational potential of green-synthesized MNPs are contextualized within the broader framework of sustainable nanomaterials development.